Adage Capital Partners’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-293,200
| Closed | -$10.2M | – | 758 |
|
2016
Q4 | $10.2M | Sell |
293,200
-1,925,000
| -87% | -$67M | 0.03% | 528 |
|
2016
Q3 | $54.4M | Sell |
2,218,200
-350,000
| -14% | -$8.58M | 0.15% | 178 |
|
2016
Q2 | $61.4M | Buy |
2,568,200
+316,393
| +14% | +$7.57M | 0.17% | 163 |
|
2016
Q1 | $52.7M | Sell |
2,251,807
-350,000
| -13% | -$8.19M | 0.14% | 181 |
|
2015
Q4 | $78.5M | Buy |
2,601,807
+603,000
| +30% | +$18.2M | 0.21% | 139 |
|
2015
Q3 | $79.4M | Buy |
1,998,807
+1,048,807
| +110% | +$41.7M | 0.22% | 128 |
|
2015
Q2 | $65.6M | Sell |
950,000
-950,000
| -50% | -$65.6M | 0.16% | 174 |
|
2015
Q1 | $104M | Sell |
1,900,000
-1,896,592
| -50% | -$104M | 0.25% | 110 |
|
2014
Q4 | $162M | Hold |
3,796,592
| – | – | 0.4% | 65 |
|
2014
Q3 | $121M | Hold |
3,796,592
| – | – | 0.3% | 85 |
|
2014
Q2 | $78.7M | Hold |
3,796,592
| – | – | 0.2% | 142 |
|
2014
Q1 | $73.5M | Hold |
3,796,592
| – | – | 0.2% | 152 |
|
2013
Q4 | $92.2M | Hold |
3,796,592
| – | – | 0.24% | 120 |
|
2013
Q3 | $81.5M | Sell |
3,796,592
-288,738
| -7% | -$6.2M | 0.23% | 126 |
|
2013
Q2 | $90.9M | Buy |
+4,085,330
| New | +$90.9M | 0.28% | 96 |
|